Brief: Enochian Biosciences Announces FDA Acceptance Of Pre-IND Request For Potential Cure For Hepatitis B Virus Infection
July 12 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES ANNOUNCES FDA ACCEPTANCE OF PRE-IND
REQUEST
FOR POTENTIAL CURE FOR HEPATITIS B VIRUS INFECTION
* ENOCHIAN BIOSCIENCES INC - FDA HAS ACCEPTED A PRE-IND
REQUEST
FOR A POTENTIAL CURE OF HEPATITIS B VIRUS (HBV) INFECTION
* ENOCHIAN BIOSCIENCES INC - WRITTEN COMMENTS ARE EXPECTED
THIS
FALL.
Source text for Eikon: ID:nGNXfFP8S
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing